Real-Time Quote
Quote | News | Chart | Details
MRK News & Analysis
 UPDATE 2-S.Africa's Aspen to sell U.S. drug rights to Mylan for up to $300 mln - 10 Sep 2014 EDT
 Can anything slow Gilead down? Analysts say no - 08 Sep 2014 EDT - CNBC.COM
 FDA OKs Merck drug, 1st in new cancer drug class - 04 Sep 2014 EDT
 Stocks close mixed ahead of ECB, data; Apple hit - 03 Sep 2014 EDT - CNBC.COM
 UPDATE 1-Zoetis granted conditional license by USDA for PEDv vaccine - 03 Sep 2014 EDT
 Zoetis granted conditional license by USDA for PEDv vaccine - 03 Sep 2014 EDT
 How China is chasing business to Singapore - 02 Sep 2014 EDT - CNBC.COM
 UPDATE 1-AstraZeneca boosted by start of new cancer drug trial - 29 Aug 2014 EDT
 Early movers: TIF, AAPL, T, AGN, PFE, TIVO & more - 27 Aug 2014 EDT - CNBC.COM
 Your first trade for Wednesday - 26 Aug 2014 EDT - CNBC.COM
Real-Time Quote
omniture pixel